Whan In Pharm Co.,Ltd. Stock price

Equities

A016580

KR7016580003

Pharmaceuticals

End-of-day quote Korea S.E. 07:00:00 2024-03-27 pm EDT 5-day change 1st Jan Change
14,500 KRW -0.89% Intraday chart for Whan In Pharm Co.,Ltd. -0.21% -3.59%
Sales 2024 * 249B 185M Sales 2025 * 271B 202M Capitalization 222B 165M
Net income 2024 * 28B 20.83M Net income 2025 * 30B 22.32M EV / Sales 2024 * 0.75 x
Net cash position 2024 * 35B 26.04M Net cash position 2025 * 43.3B 32.22M EV / Sales 2025 * 0.66 x
P/E ratio 2024 *
9.65 x
P/E ratio 2025 *
8.87 x
Employees 553
Yield 2024 *
2.07%
Yield 2025 *
2.07%
Free-Float 59.11%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.89%
1 week-0.21%
Current month+1.68%
1 month-1.16%
3 months-3.59%
6 months+4.17%
Current year-3.59%
More quotes
1 week
14 390.00
Extreme 14390
14 680.00
1 month
14 210.00
Extreme 14210
14 680.00
Current year
13 650.00
Extreme 13650
15 570.00
1 year
12 410.00
Extreme 12410
16 650.00
3 years
12 410.00
Extreme 12410
23 550.00
5 years
9 950.00
Extreme 9950
23 550.00
10 years
9 950.00
Extreme 9950
29 000.00
More quotes
Managers TitleAgeSince
Chief Executive Officer 49 05-12-31
Chief Executive Officer 76 78-05-31
Chief Tech/Sci/R&D Officer 51 -
Members of the board TitleAgeSince
Chief Executive Officer 76 78-05-31
Chief Executive Officer 49 05-12-31
Director/Board Member 50 16-03-17
More insiders
Date Price Change Volume
24-03-28 14,500 -0.89% 19,313
24-03-27 14,630 +0.21% 9,195
24-03-26 14,600 0.00% 15,483
24-03-25 14,600 +0.27% 16,506
24-03-22 14,560 +0.21% 10,918

End-of-day quote Korea S.E., March 27, 2024

More quotes
Whan In Pharm Co.,Ltd. is a Korea-based company specialized in the manufacturing of pharmaceutical products. The Company's products consist of antidepressants, antipsychotics, anxiolytics, hypnotics, antiepileptics, attention-deficit/hyperactivity disorder (ADHD) agents, nootropics, antiparkinson drugs, anti-dementia drugs, gastrointestinal drugs, cardiovascular drugs, immunostimulating agents, antibiotics, multi-vitamins, respiratory drugs, dermatologic drugs, antivirals, anti-diabetic agents and others. The Company also involves in the real estate rental business.
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
14,500 KRW
Average target price
21,000 KRW
Spread / Average Target
+44.83%
Consensus

Quarterly revenue - Rate of surprise

  1. Stock
  2. Equities
  3. Stock Whan In Pharm Co.,Ltd. - Korea S.E.